tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call
PremiumCompany AnnouncementsAmphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call
3M ago
Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Amphastar Pharmaceuticals: Strong Q3 Performance and Promising Pipeline Justify Buy Rating
3M ago
Amphastar Pharmaceuticals Reports Q3 2025 Earnings
Premium
Company Announcements
Amphastar Pharmaceuticals Reports Q3 2025 Earnings
3M ago
Amphastar price target lowered to $31 from $32 at BofA
PremiumThe FlyAmphastar price target lowered to $31 from $32 at BofA
4M ago
Amphastar Signs $2.8M Research Agreement with Hanxin
Premium
Company Announcements
Amphastar Signs $2.8M Research Agreement with Hanxin
4M ago
Amphastar price target raised to $32 from $28 at BofA
Premium
The Fly
Amphastar price target raised to $32 from $28 at BofA
5M ago
Amphastar upgraded to Buy from Hold at Needham
PremiumThe FlyAmphastar upgraded to Buy from Hold at Needham
6M ago
Amphastar Pharmaceuticals Enters Strategic Licensing Agreement
Premium
Company Announcements
Amphastar Pharmaceuticals Enters Strategic Licensing Agreement
6M ago
Cautious Hold Rating on Amphastar Pharmaceuticals Amid Uncertain Product Approvals and Flat Revenue Growth
Premium
Ratings
Cautious Hold Rating on Amphastar Pharmaceuticals Amid Uncertain Product Approvals and Flat Revenue Growth
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100